missing translation for 'onlineSavingsMsg'
Learn More
Learn More
alpha-Synuclein Mouse anti-Human, Clone: 970114, R&D Systems™
Mouse Monclonal Antibody
Brand: R&D Systems MAB13383-SP
This item is not returnable.
View return policy
Description
alpha-Synuclein Monoclonal specifically detects alpha-Synuclein in Human samples. It is validated for Western Blot, Immunohistochemistry.Specifications
alpha-Synuclein | |
Monoclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. | |
alpha-synuclein, I+/--synuclein, MGC110988, NACP, non A-beta component of AD amyloid, Non-A beta component of AD amyloid, Non-A4 component of amyloid precursor, PARK1, PARK4, PD1, SNCA, synuclein alpha-140, synuclein, alpha (non A4 component of amyloid precursor), Synuclein-alpha, truncated alpha synuclein | |
E. coli-derived recombinant human alpha-Synuclein Met1-Ala140 Accession # P37840 | |
25 μg | |
Primary | |
Detects human alpha-Synuclein in direct ELISAs. | |
Human | |
Purified |
Western Blot, Immunohistochemistry | |
970114 | |
Western Blot 5 ug/mL, Immunohistochemistry 5-25 ug/mL | |
P37840 | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
6622 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG1 |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
For Research Use Only (RUO)
Spot an opportunity for improvement?Share a Content Correction